Dr. Lena Sharpe had processed hundreds of stool samples in her career, but never one that made her pause like this.
She reran it. Same result.
Lena wasn’t amused. She pulled up the donor metadata again. Donor K was part of a longitudinal study on diet and inflammation. His previous samples—collected three months ago—were normal: 120 ng/µl, typical Firmicutes-to-Bacteroidetes ratio. But this new sample? It looked like someone had poured a concentrated culture of E. coli directly into the Qiagen bead tube before shipping. qiagen stool kit
260/230 ratio: 1.98. Perfect. 260/280 ratio: 2.12. Also perfect. But the concentration was 37 times higher than the average human stool DNA yield. Same result
Someone had taken an empty Qiagen PowerFecal Pro bead tube, spiked it with a pure, unknown bacterial isolate and a trace of factory control DNA, and sent it through the clinical collection system as a real human stool sample. Donor K was part of a longitudinal study
Then she noticed something else. The internal control spike-in (a synthetic DNA fragment added by Qiagen to track inhibition) was absent . That meant the sample hadn’t inhibited the PCR—it had overwhelmed it. The control was present but undetectable because the background DNA was so massive.
She didn’t sleep that night. By morning, she had sequenced 1 million reads of the sample’s 16S rRNA gene.
